Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin for infection prevention in inguinal hernioplasty
NCT00636831Phase 3Completed
- Sponsor
- Nihon University
- Start
- Jul 2007
- Primary completion
- Jan 2012
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cefazolin in inguinal hernia, sponsored by Nihon University. Primary endpoint: Infectious complication at 2 years. Started Jul 2007; status: completed.
02
Drugs
cefazolin
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on NCT00636831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636831.